TVGN — Tevogen Bio Holdings Share Price
0.000.00%
Last trade - 00:00- $182.46m
- $189.59m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company. The Company is harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs), to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the unmet needs of patient populations. Its first product candidate, TVGN 489, has developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic lingering symptoms of the disease. Its TVGN 601 is being developed for multiple sclerosis (MS), and its TVGN 930 is being developed for EBV-associated lymphomas.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- February 13th, 2024
- Public Since
- November 4th, 2021
- No. of Employees
- 17
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- NASDAQ Global Market
- Shares in Issue
- 183,893,433
- Address
- 15 Independence Boulevard, Suite 410, WARREN, 07059
- Web
- https://tevogen.com/
- Phone
- +1 6468078832
- Auditors
- Marcum LLP
Upcoming Events for TVGN
Tevogen Bio Holdings Inc Annual Shareholders Meeting
Q2 2025 Tevogen Bio Holdings Inc Earnings Release
Similar to TVGN
89bio
NASDAQ Global Market
Abivax SA
NASDAQ Global Market
ABPRO Holdings
NASDAQ Global Market
AC Immune SA
NASDAQ Global Market
Acrivon Therapeutics
NASDAQ Global Market
FAQ
What is the Tevogen Bio Holdings share price?
As of Today at 23:39 UTC, shares in Tevogen Bio Holdings are trading at $0.99. This share price information is delayed by 15 minutes.
How has the Tevogen Bio Holdings share price performed this year?
Shares in Tevogen Bio Holdings last closed at $0.99 and the price had moved by +16.73% over the past 365 days. In terms of relative price strength the Tevogen Bio Holdings share price has outperformed the S&P500 Index by +7.75% over the past year.
What are the analyst and broker recommendations for Tevogen Bio Holdings?
The overall consensus recommendation for Tevogen Bio Holdings is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Tevogen Bio Holdings dividend yield?
Tevogen Bio Holdings does not currently pay a dividend.
Does Tevogen Bio Holdings pay a dividend?
Tevogen Bio Holdings does not currently pay a dividend.
When does Tevogen Bio Holdings next pay dividends?
Tevogen Bio Holdings does not currently pay a dividend.
How do I buy Tevogen Bio Holdings shares?
To buy shares in Tevogen Bio Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Tevogen Bio Holdings?
As of the previous close price of $0.99, shares in Tevogen Bio Holdings had a market capitalisation of $182.46m.
Where are Tevogen Bio Holdings shares listed?
Here are the trading details for Tevogen Bio Holdings:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: TVGN
What kind of share is Tevogen Bio Holdings?
Based on an overall assessment of its quality, value and momentum Tevogen Bio Holdings is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Tevogen Bio Holdings share price forecast for 2025?
The analyst consensus target price for shares in Tevogen Bio Holdings is $7.10. That is 615.58% above the last closing price of $0.99.
Analysts covering Tevogen Bio Holdings currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Tevogen Bio Holdings share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tevogen Bio Holdings. Over the past six months, its share price has underperformed the S&P500 Index by -65.71%.
As of the last closing price of $0.99, shares in Tevogen Bio Holdings were trading -7.24% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Tevogen Bio Holdings PE Ratio?
The Tevogen Bio Holdings PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.99.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Tevogen Bio Holdings?
We do not have data on Tevogen Bio Holdings' directors